Hong Kong

  This was an open-label, randomized trial comparing clinical outcomes of those on triple combination therapy to those on lopinavir-ritonavir alone, which found that early triple antiviral therapy was safe and superior to lopinavir-ritonavir alone in alleviating symptoms and shortening Read More
This study showed that border restrictions, quarantine and isolation, distancing, and changes in population behavior were associated with reduced transmission of COVID-19 and influenza in Hong Kong. Hong Kong has engaged in a number of measures to handle the COVID-19 Read More

Get Involved with Indiana CTSI